Moderate Neonatal Pulmonary & Metabolic Dysfunctions

Transient Tachypnea of the Newborn (TTN)

Neonatal Alveolar Fluid Clearance Delay Syndrome

Primary risk age: Term or near-term newborns (onset immediately at birth or within 2 hours)

Urgency: Moderate
Typical age: Term or near-term newborns (onset immediately at birth or within 2 hours)
Body system: Neonatal (Newborns)

Typical course: Resolves fully in 1 to 3 days.

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Neonatal Alveolar Fluid Clearance Delay Syndrome

Pathophysiology (Development Path)

During labor, epinephrine triggers type II alveolar cells to switch from fluid secretion to fluid absorption via epithelial sodium channels (ENaC). If this process is delayed or bypassed (as in C-section), residual lung fluid remains in the alveoli and lymphatic spaces. This causes lung compliance to drop, leading to tachypnea and mild hypoxemia.

Primary Causes & Etiology

Delayed clearance of fetal alveolar fluid at birth; highly associated with Cesarean delivery (lack of labor squeeze) and maternal asthma or diabetes.

2. Symptom Continuum

Early Onset Signs
Tachypnea (respiratory rate exceeding 60 breaths/minute) presenting immediately after birth.
Progressive Phase
Respiratory rate increasing up to 80-100 breaths/minute, mild intercostal/subcostal retractions, and expiratory grunting.
Severe Indicators
Nasal flaring, mild cyanosis on room air requiring low-flow oxygen, resolving completely within 24 to 72 hours.

3. Clinical Verification

Chest X-ray showing hyperinflation, prominent vascular markings radiating from the hilum ("wet lungs"), and fluid in the fissures. Normal arterial blood gas.

4. Care & Elements Plan

Primary Care Treatment Plan

Supportive monitoring. Administer low-flow supplemental oxygen via nasal cannula if needed. Provide CPAP for moderate cases. Delay oral feeding if respiratory rate exceeds 80 to prevent aspiration.

Home Support Elements

Home care is not applicable. The condition is self-limiting and resolves fully in the hospital within the first few days of life.

Generic Active Ingredients (No Brands)

None. No diuretics or steroids are indicated
supportive fluid management and oxygen are the mainstays of care.

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

Any newborn showing rapid breathing or grunting in the delivery room or nursery requires immediate neonatal evaluation.

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

Avoid elective Cesarean deliveries before 39 weeks gestation to allow natural labor mechanisms to clear lung fluid.

Immunization Context

No specific immunizations are associated with this self-limiting condition.

7. Timelines & Outlook

Active Timeline

Resolves fully in 1 to 3 days.

Expected Prognosis

Outstanding. The condition is benign and resolves completely within 24 to 72 hours without long-term pulmonary complications.

Potential Untreated Complications

Aspiration pneumonia (if fed while breathing rapidly) and pneumothorax (rare, if aggressive CPAP is applied).

Emergency

Neonatal Respiratory Distress Syndrome (RDS)

Neonatal Surfactant Deficiency Pulmonary Disease

Premature Neonates (Incidence increases with decreasing gestational age; rare in term infants)

Moderate

Neonatal Jaundice (Hyperbilirubinemia)

Neonatal Bilirubin Metabolic Clearance Dysfunction

Neonates (Common in the first week of life; affects up to 60% of term and 80% of preterm infants)